AREDS 2 Study Results
AREDS 2 participants had significantly higher baseline serum levels of Zeaxanthin and Lutein compared to the general population. Based on the average American intake of one milligram of dietary Zeaxanthin and Lutein per day, it is reasonable to infer that most patients would benefit from a higher intake of Zeaxanthin and Lutein.
Supplementation with Zeaxanthin and Lutein slowed progression to advanced AMD an additional 10 percent over the original AREDS 2 formula in the overall AREDS 2 study population. EyePromise AREDS 2 Plus with a Multi-Vitaminis formulated for:
- All individuals who want better eye health
- Low Macular Pigment Optical Density (MPOD)
- Improved visual performance
|*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease|